Publicaciones en las que colabora con MARÍA ISABEL FABREGAT ROMERO (9)

2024

  1. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche

    Journal of Pathology, Vol. 263, Núm. 4-5, pp. 482-495

  2. Uncovering a Novel Functional Interaction Between Adult Hepatic Progenitor Cells, Inflammation and EGFR Signaling During Bile Acids-Induced Injury

    International Journal of Biological Sciences, Vol. 20, Núm. 7, pp. 2339-2355

2022

  1. Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response

    Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324

2016

  1. Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis

    Hepatology, Vol. 63, Núm. 2, pp. 604-619

2012

  1. Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes

    Journal of Biological Chemistry, Vol. 287, Núm. 19, pp. 15263-15274

2004

  1. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes

    Hepatology, Vol. 40, Núm. 6, pp. 1285-1294

  2. Transforming growth factor-beta activates both pro-apoptotic and survival signals in fetal rat hepatocytes

    Experimental Cell Research, Vol. 292, Núm. 1, pp. 209-218

2003

  1. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes

    Diabetes, Vol. 52, Núm. 9, pp. 2239-2248

2000

  1. Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor β in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway

    Hepatology, Vol. 32, Núm. 3, pp. 528-535